Andrew J. Last
Chief Operating Officer, Bio-Rad Laboratories.
Companies
- Insight Molecular Diagnostics Inc.Board member Dec 30, 2015 to now1
- Bio-Rad LaboratoriesChief operating officer Apr 24, 2019 to Sep 10, 20242
- Precigen, IncChief operating officer Aug 31, 2016 to Nov 15, 20173
- AffymetrixChief operating officer Feb 13, 2014 to Apr 1, 20164
- AffymetrixChief Commercial Officer Feb 26, 2010 to Dec 18, 20135
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Bio-Rad Laboratories BIO7,559 shares6$2.7M at $354.24Sep 6, 2024- Insight Molecular Diagnostics Inc. IMDX58,752 shares7$173.3K at $2.95Jul 1, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 1, 2026Shares withheld for tax 7,700 shares at $5.69 of Insight Molecular Diagnostics Inc.7
- Jun 11, 2026Granted 26,943 shares of Insight Molecular Diagnostics Inc.8
- Jul 1, 2025Granted 35,000 shares of Insight Molecular Diagnostics Inc.9
- Sep 6, 2024Sold 3,000 shares at $329.94 of Bio-Rad Laboratories6
- Sep 6, 2024Exercised options 3,000 shares at $299.24 of Bio-Rad Laboratories6
- Sep 2, 2024Shares withheld for tax 458 shares at $337.32 of Bio-Rad Laboratories10
- Sep 2, 2024Exercised options 903 shares of Bio-Rad Laboratories10
- Sep 1, 2024Shares withheld for tax 321 shares at $337.32 of Bio-Rad Laboratories10
- Sep 1, 2024Exercised options 633 shares of Bio-Rad Laboratories10
- Sep 1, 2024Shares withheld for tax 440 shares at $337.32 of Bio-Rad Laboratories10
- Sep 1, 2024Exercised options 867 shares of Bio-Rad Laboratories10
- Sep 1, 2024Shares withheld for tax 635 shares at $337.32 of Bio-Rad Laboratories10
- Sep 1, 2024Exercised options 1,252 shares of Bio-Rad Laboratories10
- Apr 29, 2024Shares withheld for tax 357 shares at $277.11 of Bio-Rad Laboratories11
- Apr 29, 2024Exercised options 1,000 shares of Bio-Rad Laboratories11
- Sep 2, 2023Shares withheld for tax 448 shares at $394.60 of Bio-Rad Laboratories12
- Sep 2, 2023Exercised options 903 shares of Bio-Rad Laboratories12
- Sep 1, 2023Shares withheld for tax 279 shares at $394.60 of Bio-Rad Laboratories12
- Sep 1, 2023Exercised options 633 shares of Bio-Rad Laboratories12
- Sep 1, 2023Shares withheld for tax 430 shares at $394.60 of Bio-Rad Laboratories12
- Sep 1, 2023Exercised options 867 shares of Bio-Rad Laboratories12
- Jun 23, 2023Granted 20,000 shares of Insight Molecular Diagnostics Inc.13
- Apr 29, 2023Shares withheld for tax 346 shares at $450.79 of Bio-Rad Laboratories14
- Apr 29, 2023Exercised options 1,000 shares of Bio-Rad Laboratories14
- Sep 2, 2022Shares withheld for tax 448 shares at $478.32 of Bio-Rad Laboratories15
Trade performance
| Date | Stock | Trade | Value | Return since | Vs S&P since | Vs S&P, 1 year |
|---|---|---|---|---|---|---|
| Sep 6, 2024 | BIO | Sale | $989.8K | +7.3% | +35.6% | +32.0% |
| Sep 1, 2021 | BIO | Sale | $1.6M | −56.6% | +127.4% | +28.1% |
Returns are price-only (no dividends), measured from the trade date.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARAffymetrix, Chief operating officer
- 5SEC EDGARAffymetrix, Chief Commercial Officer
- 6
- 7
- 8SEC EDGARForm 4 filed Jun 15, 2026
- 9SEC EDGARForm 4 filed Jul 3, 2025
- 10SEC EDGARForm 4 filed Sep 4, 2024
- 11SEC EDGARForm 4 filed Apr 30, 2024
- 12SEC EDGARForm 4 filed Sep 6, 2023
- 13SEC EDGARForm 4 filed Jun 27, 2023
- 14SEC EDGARForm 4 filed May 1, 2023
- 15SEC EDGARForm 4 filed Sep 7, 2022